These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7710267)

  • 41. Nucleic acid related compounds. 65. New syntheses of 1-(beta-D-arabinofuranosyl)-5(E)-(2-iodovinyl)uracil (IVAraU) from vinylsilane precursors. Radioiodine uptake as a marker for thymidine kinase positive herpes viral infections.
    Robins MJ; Manfredini S; Wood SG; Wanklin RJ; Rennie BA; Sacks SL
    J Med Chem; 1991 Jul; 34(7):2275-80. PubMed ID: 2067000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sorivudine and 5-fluorouracil; a clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase.
    Diasio RB
    Br J Clin Pharmacol; 1998 Jul; 46(1):1-4. PubMed ID: 9690942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enzymatic synthesis of 2'-O-acyl prodrugs of 1-(beta-D-arabinofuranosyl)-5(E)-(2-bromovinyl)uracil and of 2'-O-acyl-araU, -araC and -araA.
    Manfredini S; Baraldi PG; Bazzanini R; Bortolotti F; Vertuani S; Ashida N; Machida H
    Antivir Chem Chemother; 1998 Jan; 9(1):25-31. PubMed ID: 9875374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanism of inhibition of DNA synthesis by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Suzutani T; Machida H; Honess RW
    Microbiol Immunol; 1993; 37(6):511-3. PubMed ID: 8231965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of sorivudine on dihydropyrimidine dehydrogenase activity in patients with acute herpes zoster.
    Yan J; Tyring SK; McCrary MM; Lee PC; Haworth S; Raymond R; Olsen SJ; Diasio RB
    Clin Pharmacol Ther; 1997 May; 61(5):563-73. PubMed ID: 9164418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiherpes activity of [E]-5-(1-propenyl)-2'-deoxyuridine and 5-(1-propenyl)-1-beta-D-arabinofuranosyluracil.
    Stening G; Gotthammar B; Larsson A; Alenius S; Johansson NG; Oberg B
    Antiviral Res; 1981 Nov; 1(4):213-23. PubMed ID: 6280606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lethal drug interactions of the new antiviral, sorivudine, with anticancer prodrugs of 5-fluorouracil].
    Watabe T; Okuda H; Ogura K
    Yakugaku Zasshi; 1997 Nov; 117(10-11):910-21. PubMed ID: 9414600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 5-substituted arabinofuranosyluracil nucleosides: synthesis and antiviral properties.
    Kulikowski T; Zawadzki Z; De Clercq E; Shugar D
    Acta Biochim Pol; 1984; 31(3):341-56. PubMed ID: 6524217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the selectivity of anti-varicella-zoster virus nucleoside analogues.
    Machida H; Nishitani M; Watanabe Y; Yoshimura Y; Kano F; Sakata S
    Microbiol Immunol; 1995; 39(3):201-6. PubMed ID: 7603364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil. A highly selective antiherpes simplex agent.
    Mansuri MM; Ghazzouli I; Chen MS; Howell HG; Brodfuehrer PR; Benigni DA; Martin JC
    J Med Chem; 1987 May; 30(5):867-71. PubMed ID: 3033244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
    Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
    BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine in the treatment of experimental herpes simplex virus encephalitis in mice.
    Park NH; Pavan-Langston D; de Clercq E
    Antiviral Res; 1983 Mar; 3(1):7-15. PubMed ID: 6870230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphoramidates of 2'-beta-D-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism.
    Mehellou Y; Valente R; Mottram H; Walsby E; Mills KI; Balzarini J; McGuigan C
    Bioorg Med Chem; 2010 Apr; 18(7):2439-46. PubMed ID: 20299228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-activity relationships of (E)-5-(2-bromovinyl)uracil and related pyrimidine nucleosides as antiviral agents for herpes viruses.
    Choi Y; Li L; Grill S; Gullen E; Lee CS; Gumina G; Tsujii E; Cheng YC; Chu CK
    J Med Chem; 2000 Jun; 43(13):2538-46. PubMed ID: 10891113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
    Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
    Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigation of antiviral activity of 1-beta-D-arabinofuranosylthymine (ara-T) and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-ara-U) in monkeys infected with simian varicella virus.
    Soike KF; Baskin G; Cantrell C; Gerone P
    Antiviral Res; 1984 Oct; 4(5):245-57. PubMed ID: 6097178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
    Okuda H; Nishiyama T; Ogura K; Nagayama S; Ikeda K; Yamaguchi S; Nakamura Y; Kawaguchi K; Watabe T; Ogura Y
    Drug Metab Dispos; 1997 Feb; 25(2):270-3. PubMed ID: 9029059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine.
    Rajcáni J; Reefschläger J
    Acta Virol; 1987 Aug; 31(4):329-39. PubMed ID: 2892382
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the in vitro and in vivo anti-herpes activities of 1-beta-D-arabinofuranosylthymine and its 5'-monophosphate.
    Machida H; Sakata S; Morozumi M; Kiyanagi T; Kuninaka A; Yoshino H
    Antiviral Res; 1982 Sep; 2(4):217-26. PubMed ID: 6293376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.